penicillamine has been researched along with Cutis Laxa in 14 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Cutis Laxa: A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with Wilson's disease who developed elastosis perforans serpiginosa and localized cutis laxa during prolonged treatment with D-penicillamine is described." | 7.69 | D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. ( Amichai, B; Metzker, A; Rotem, A, 1994) |
| "We report a chromosomally normal infant boy with congenital diffuse cutis laxa, severe micrognathia, contractures of all limbs, and central nervous system abnormalities including agenesis of the corpus callosum, born to a woman taking D-penicillamine (DP) for Wilson disease (WD) throughout her pregnancy." | 3.72 | Infant with severe penicillamine embryopathy born to a woman with Wilson disease. ( Hogge, WA; McPherson, E; Pinter, R, 2004) |
| "A patient with Wilson's disease who developed elastosis perforans serpiginosa and localized cutis laxa during prolonged treatment with D-penicillamine is described." | 3.69 | D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. ( Amichai, B; Metzker, A; Rotem, A, 1994) |
| "Excellent treatment options exist for Wilson disease, based on copper chelation." | 2.49 | Inborn errors of copper metabolism. ( Kaler, SG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaler, SG | 1 |
| Hellriegel, S | 1 |
| Bertsch, HP | 1 |
| Emmert, S | 1 |
| Schön, MP | 1 |
| Haenssle, HA | 1 |
| Vajdi, T | 1 |
| Lee, WW | 1 |
| Paravar, T | 1 |
| Pinter, R | 1 |
| Hogge, WA | 1 |
| McPherson, E | 1 |
| Rosen, LB | 1 |
| Muellenhoff, M | 1 |
| Tran, TT | 1 |
| Muhart, M | 1 |
| Harpey, JP | 1 |
| Jaudon, MC | 1 |
| Clavel, JP | 1 |
| Galli, A | 1 |
| Darbois, Y | 1 |
| Amichai, B | 1 |
| Rotem, A | 1 |
| Metzker, A | 1 |
| Hill, VA | 1 |
| Seymour, CA | 1 |
| Mortimer, PS | 1 |
| Poon, E | 1 |
| Mason, GH | 1 |
| Oh, C | 1 |
| Siegel, RC | 1 |
| Linares, A | 1 |
| Zarranz, JJ | 1 |
| Rodriguez-Alarcon, J | 1 |
| Diaz-Perez, JL | 1 |
| Walshe, JM | 1 |
| Grahame, R | 1 |
| Harvey, W | 1 |
| Rosa, FW | 1 |
3 reviews available for penicillamine and Cutis Laxa
| Article | Year |
|---|---|
Inborn errors of copper metabolism.
Topics: Chelating Agents; Child; Copper; Cutis Laxa; Ehlers-Danlos Syndrome; Hepatolenticular Degeneration; | 2013 |
Penicillamine-associated cutis laxa and milia en plaque - case report and review of cutaneous changes associated with penicillamine.
Topics: Aged; Chelating Agents; Cutis Laxa; Cystinuria; Humans; Male; Penicillamine; Sweat Gland Diseases | 2016 |
Lysyl oxidase.
Topics: Amino Acid Oxidoreductases; Aneurysm; Animals; Chickens; Collagen; Copper; Cutis Laxa; Dogs; Ehlers- | 1979 |
11 other studies available for penicillamine and Cutis Laxa
| Article | Year |
|---|---|
Elastosis perforans serpiginosa: a case of a penicillamine-induced degenerative dermatosis.
Topics: Aged; Chelating Agents; Cutis Laxa; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Penici | 2014 |
Infant with severe penicillamine embryopathy born to a woman with Wilson disease.
Topics: Abnormalities, Drug-Induced; Agenesis of Corpus Callosum; Cutis Laxa; Female; Fetal Diseases; Fetus; | 2004 |
Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa.
Topics: Chelating Agents; Connective Tissue Diseases; Cutis Laxa; Female; Humans; Middle Aged; Penicillamine | 2005 |
Cutis laxa and low serum zinc after antenatal exposure to penicillamine.
Topics: Adult; Cutis Laxa; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Penicillamine; Pregnanc | 1983 |
D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease.
Topics: Child; Connective Tissue Diseases; Cutis Laxa; Elastic Tissue; Female; Hepatolenticular Degeneration | 1994 |
Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
Topics: Adult; Chelating Agents; Cutis Laxa; Elastic Tissue; Hepatolenticular Degeneration; Humans; Male; Pe | 2000 |
Clinical and histological spectrum of elastotic changes induced by penicillamine.
Topics: Aged; Chelating Agents; Cutis Laxa; Drug Eruptions; Humans; Male; Penicillamine; Skin | 2002 |
Reversible cutis laxa due to maternal D-penicillamine treatment.
Topics: Cutis Laxa; Female; Fetus; Hepatolenticular Degeneration; Humans; Infant, Newborn; Infant, Newborn, | 1979 |
Congenital cutis laxa and maternal D-penicillamine.
Topics: Cutis Laxa; Female; Fetus; Humans; Infant, Newborn; Penicillamine; Pregnancy | 1979 |
Cutaneous extensibility in health and disease.
Topics: Acromegaly; Adolescent; Adult; Aged; Aging; Child; Child, Preschool; Collagen; Cutis Laxa; Ehlers-Da | 1975 |
Teratogen update: penicillamine.
Topics: Abnormalities, Drug-Induced; Animals; Collagen; Copper; Cutis Laxa; Female; Hepatolenticular Degener | 1986 |